MedTrace Logo

Protein Ingestion on BMM Response in Endurance Runners

NCT06645119 · Status: ACTIVE_NOT_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 14

Last updated 2025-05-08

No results posted yet for this study

Summary

The goal of this clinical trial is to investigate the effects of protein ingestion post-exercise on bone turnover markers. The main questions it aims to answer is:

Does protein ingestion independently influence the bone metabolic response to exercise in endurance runners?

We will compare dietary protein to a placebo (water) to detect changes in bone turnover markers.

Participants will:

In a within-subject design, participants will perform an exhaustive run and take either protein or placebo immediately post-exercise.

Track physical activity and diet before each arm of the intervention and during the washout period.

Conditions

  • Dietary Proteins
  • Acute Exercise
  • Bone Diseases, Metabolic

Interventions

DIETARY_SUPPLEMENT

Whey Protein Supplement

Examining the independent effect of post-exercise dietary protein ingestion on bone metabolic markers.

Sponsors & Collaborators

Principal Investigators

  • Jenna Gibbs, PhD · McGill University

Study Design

Allocation
RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
DOUBLE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
35 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2024-03-01
Primary Completion
2025-01-24
Completion
2025-09-01

Countries

  • Canada

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06645119 on ClinicalTrials.gov